As reported yesterday, the Treasury has produced a detailed cost-benefit analysis of establishing a legally regulated cannabis market in the UK. The report is largely based on existing research (PDF) carried out by the Beckley Foundation and the Institute for Social and Economic Research at the University of Essex and the, but updates and critiques some of that analysis.
On Monday 12 October, at 4.30pm, MPs will debate the legalisation of cannabis in Westminster Hall. The debate results from an e-petition that garnered more than 220,000 signatures.
When I found out about the new #CrushDabWait campaign launched last week I felt relieved that common sense was finally prevailing. My only wish is that this campaign had existed 23 months ago before I lost my only child to an accidental ecstasy overdose.

All the main UK political parties have now published their manifestos, setting out their stalls ahead of the general election on 7 May. Here are their positions on drug policy.

If drug use is going down, then isn’t this proof that our approach to drugs is working? It seems at first glance like a reasonable assumption to make. The Prime Minister certainly thought it was a plausible counter-argument to the widespread calls for decriminalisation witnessed last week.
The long-delayed report released today by the Home Office highlights how its own approach to drugs is not based on evidence. In particular, the report – which looks at the effectiveness of other countries’ drug policies – concludes that harsh penalties for drug users have no effect on levels of drug use.
In advance of the parliamentary debate on UK drug policy this Thursday, 30 October, Release and Transform sent the briefing below to all 650 MPs, to highlight why this debate is so important and why an impact assessment of current policy is so badly needed.